CVD.TO vs. VRNA

Last updated Jun 4, 2026

CVD.TO (iShares Convertible Bond Index ETF) is High Yield Bonds fund tracking the FTSE Canada Convertible Bond Index, while VRNA (Verona Pharma plc) is a stock. At a 0.05 correlation, their price movements are largely independent.

Performance

CVD.TO vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in iShares Convertible Bond Index ETF (CVD.TO) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CVD.TO is traded in CAD, while VRNA is traded in USD. To make them comparable, the VRNA values have been converted to CAD using the latest available exchange rates.

Returns By Period

CVD.TO

• 1D: -0.28%
• 1M: 0.49%
• YTD: 3.23%
• 6M: 0.06%
• 1Y: 7.61%
• 3Y*: 7.90%
• 5Y*: 4.33%
• 10Y*: 4.53%

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CVD.TO vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CVD.TO iShares Convertible Bond Index ETF	3.23%	7.09%	12.68%	3.64%	-4.63%	5.33%	3.67%	10.28%	-2.68%	1.73%
VRNA Verona Pharma plc	0.00%	123.30%	153.67%	-25.59%	316.55%	-4.87%	19.68%	-43.34%	-11.82%	-18.85%

Correlation

The correlation between CVD.TO and VRNA is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (All Time) Calculated using the full available price history since Apr 28, 2017	0.05

Return for Risk

CVD.TO vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVD.TO

CVD.TO Risk / Return Rank: 33
CVD.TO Sharpe Ratio Rank: 29
CVD.TO Sortino Ratio Rank: 27
CVD.TO Omega Ratio Rank: 32
CVD.TO Calmar Ratio Rank: 39
CVD.TO Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CVD.TO vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Convertible Bond Index ETF (CVD.TO) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CVD.TO	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	1.05	—	—
Sortino ratio: Return per unit of downside risk	1.48	—	—
Omega ratio: Gain probability vs. loss probability	1.22	—	—
Calmar ratio: Return relative to maximum drawdown	1.93	—	—
Martin ratio: Return relative to average drawdown	5.61	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CVD.TO	VRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.05	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.46	—	—

Drawdowns

Drawdown Indicators

	CVD.TO	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-23.51%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-3.95%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-11.47%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-14.62%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-23.51%	—	—
Current Drawdown Current decline from peak	-2.00%	—	—
Average Drawdown Average peak-to-trough decline	-2.39%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	1.36%	—	—

Volatility

Volatility by Period

	CVD.TO	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.95%	—	—
Volatility (6M) Calculated over the trailing 6-month period	5.52%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	7.29%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	9.25%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	9.43%	—	—

Dividends

CVD.TO vs. VRNA - Dividend Comparison

CVD.TO's dividend yield for the trailing twelve months is around 4.95%, while VRNA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CVD.TO iShares Convertible Bond Index ETF	4.95%	4.91%	5.14%	5.33%	5.05%	4.61%	4.48%	4.52%	4.97%	4.65%	4.51%	4.94%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CVD.TO and VRNA in my portfolio?

CVD.TO and VRNA have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.